Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
about
Evolving treatment paradigms for chemotherapy-induced nausea and vomitingDelayed Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Incidence, and Current ManagementImpact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.Pattern of prophylaxis administration for chemotherapy-induced nausea and vomiting: an analysis of city-based health insurance data.Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study.Effect of acupuncture in prevention and treatment of chemotherapy-induced nausea and vomiting in patients with advanced cancer: study protocol for a randomized controlled trial.APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: a post hoc subgroPalonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy.Assessing quality of life on the day of chemotherapy administration underestimates patients' true symptom burden.Rolapitant for the treatment of chemotherapy-induced nausea and vomiting: a review of the clinical evidence.Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy.Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting.Helping patients discuss CINV management: development of a Patient Charter.Comparison of the Control of Nausea and Vomiting among Several Moderately Emetic-Risk Chemotherapy Regimens.Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapyChemotherapy-induced nausea and vomiting: exploring patients' subjective experience.Problem-solving strategies of women undergoing chemotherapy for breast cancerControl of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimensChemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance).Integrative review of factors related to the nursing diagnosis nausea during antineoplastic chemotherapy.Identifying early dehydration risk with home-based sensors during radiation treatment: a feasibility study on patients with head and neck cancer.Chemotherapy-induced complications in patients with lung cancer: An evaluation by pharmacists.Differential pharmacology and clinical utility of rolapitant in chemotherapy-induced nausea and vomiting.Addressing the value of novel therapies in chemotherapy-induced nausea and vomiting.Placebo interventions for nausea: a systematic review.The role of netupitant and palonosetron in chemotherapy-induced nausea and vomiting.Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02).APF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapy.Controlling chemotherapy-induced nausea requires further improvement: symptom experience and risk factors among Korean patients.Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy.Gaps exist between patients' experience and clinicians' awareness of symptoms after chemotherapy: CINV and accompanying symptoms.Patient-practitioner perception gap in treatment-induced nausea and vomiting.Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries.Rationale and design of the Pan Australasian chemotherapy-induced emesis burden of illness study.Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin.The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer.A Study on Utilization and Evaluation of Antiemetics in Chemotherapy-induced Nausea and Vomiting.Applicability of the National Comprehensive Cancer Network/Multinational Association of Supportive Care in Cancer Guidelines for Prevention and Management of Chemotherapy-Induced Nausea and Vomiting in Southeast Asia: A Consensus Statement.Gender differences in clinical registration trials; is there a real problem?
P2860
Q27024463-F72DC399-8BFB-454B-8099-E216C4F4090FQ30235971-A2DD84E0-4BE7-481D-B67C-C06188774B27Q30316569-9647304A-6DA4-4761-A4BD-50D47227DEAFQ30570659-4434C923-7A68-4D7A-80EE-AA8CE38845CFQ30973575-B341C0E6-9FCC-490E-A991-85D7EA3941A3Q33587206-A62C73E5-E135-46A5-9D0A-1B53E4293752Q33734386-3B1B88CD-CDA1-420D-ADC3-F330CA53392FQ34166946-7A7BE587-69E4-48CE-B2D6-3FFC6B9E2C7DQ34346531-2FD57721-F28B-48F0-99DB-E7D35F3A7A09Q34512212-6F27250F-6EEC-4E09-8A2D-2041ED421C33Q36222937-3D9B4807-D724-4347-9F91-212F2B3C579FQ36416256-B2FC2BD1-0063-44D8-99B3-94BB3CE48678Q36755026-33BCB246-6B58-4DF6-B543-D412C0A5BDA8Q36764931-512400C3-E084-4EA5-A982-85AF3EC80A1EQ36778149-5DAFC695-635C-4D2C-A5BD-CCAF36910DAFQ36798046-A38640C1-C6E9-4BE8-8995-9F88A7F2F78FQ36865684-42C3B9E1-4454-42A1-975E-424AB91E83E6Q37139336-573F9FA0-FDDD-491F-AB3C-2BF7D6FE89B5Q37174198-87BDD648-2AE3-41D0-8E0A-E549BC9FD559Q37347921-205A5C3E-C832-46E8-9215-451FD177F418Q37438294-4576954C-0A11-4940-99B0-D4276AAEF433Q37641073-13546ECC-2677-460B-B7A0-F7D97DC77032Q37669043-D52C5948-9F71-4310-AF98-13D3E7D987F1Q38250191-70FC8226-8968-46A6-A34B-703D83531994Q38290777-22838743-A30D-435A-B917-DC17A3325825Q38443441-B9895F4D-E3CD-4016-AB67-82C594B83AF6Q38705385-0F80FC58-2F31-4B62-BD7E-2E11B4A3FB39Q38892469-A72FC1AB-A8E4-4BE7-9068-82D1F3EADC4AQ38894275-73F06CEC-3968-4540-9D60-1B2EA367E365Q38943088-C272AE05-3C0B-4CF4-A668-9F69E49042E6Q39275766-0C1C0162-CB32-4A6F-B9F6-7CD362B931CEQ39698913-8CBC42B7-9477-4ED4-BD3B-50720E639A43Q40586658-2285B1BE-1313-4CD5-926A-AB38E6F0058BQ43571282-7C94E773-3B5A-462C-BC31-156A55957E05Q43764003-1912FE90-C99A-4A92-85F6-3C43A9A535A4Q44165565-AEC79B36-A0A9-4B26-8563-03B40690C3C4Q46027938-796D9F01-2DA3-4B56-9929-C230D2D0B4DBQ47112651-2B41532D-5C97-4933-9145-E9C2F07EC0C3Q47135544-74EBB187-303B-46FD-B113-A636A351CB0EQ47224501-7D224137-0383-4940-8A99-FB48673D8DA1
P2860
Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Chemotherapy-induced nausea an ...... ommunity hospital-based study.
@ast
Chemotherapy-induced nausea an ...... ommunity hospital-based study.
@en
Chemotherapy-induced nausea an ...... ommunity hospital-based study.
@nl
type
label
Chemotherapy-induced nausea an ...... ommunity hospital-based study.
@ast
Chemotherapy-induced nausea an ...... ommunity hospital-based study.
@en
Chemotherapy-induced nausea an ...... ommunity hospital-based study.
@nl
prefLabel
Chemotherapy-induced nausea an ...... ommunity hospital-based study.
@ast
Chemotherapy-induced nausea an ...... ommunity hospital-based study.
@en
Chemotherapy-induced nausea an ...... ommunity hospital-based study.
@nl
P2093
P2860
P1476
Chemotherapy-induced nausea an ...... ommunity hospital-based study.
@en
P2093
Chad M Gundy
Doranne L Hilarius
Elsken van der Wall
Joris J G van den Heuvel
Neil K Aaronson
Paul H Kloeg
P2860
P2888
P304
P356
10.1007/S00520-010-1073-9
P577
2011-01-22T00:00:00Z